{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T07:31:15Z","timestamp":1787729475331,"version":"build-2784847793"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-156429"],"award-info":[{"award-number":["PJT-156429"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-162126"],"award-info":[{"award-number":["PJT-162126"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019175","name":"Scleroderma Society of Ontario","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019175","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>More people with rare diseases likely receive disease education and emotional and practical support from peer-led support groups than any other way. Most rare-disease support groups are delivered outside of the health care system by untrained leaders. Potential benefits may not be achieved and harms, such as dissemination of inaccurate information, may occur. Our primary objective was to evaluate the effects of a rare-disease support group leader education program, which was developed collaboratively by researchers, peer support group leaders, and patient organization leaders, compared to waitlist control, on peer leader self-efficacy among scleroderma support group leaders.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The trial was a pragmatic, two-arm partially nested randomised controlled trial with 1:1 allocation into intervention or waitlist control. Eligible participants were existing or candidate peer support group leaders affiliated with a scleroderma patient organization. Leader training was delivered in groups of 5\u20136 participants weekly for 13\u00a0weeks in 60\u201390\u00a0min sessions via the GoToMeeting\u00ae videoconferencing platform. The program included 12 general leader training modules and one module specific to scleroderma. Primary outcome was leader self-efficacy, measured by the Support Group Leader Self-efficacy Scale (SGLSS) immediately post-intervention. Secondary outcomes were leader self-efficacy 3\u00a0months post-intervention; emotional distress, leader burnout, and volunteer satisfaction post-intervention and 3\u00a0months post-intervention; and program satisfaction among intervention participants post-intervention.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>One hundred forty-eight participants were randomised to intervention (N\u2009=\u200974) or waitlist (N\u2009=\u200974). Primary outcome data were provided by 146 (99%) participants. Mean number of sessions attended was 11.4 (standard deviation\u2009=\u20092.6). Mean program satisfaction score (CSQ-8) was 30.3 (standard deviation\u2009=\u20093.0; possible range 8\u201332). Compared to waitlist control, leader self-efficacy was higher post-intervention [SGLSS; 16.7 points, 95% CI 11.0\u201322.3; standardized mean difference (SMD) 0.84] and 3\u00a0months later (15.6 points, 95% CI 10.2\u201321.0; SMD 0.73); leader volunteer satisfaction was significantly higher at both assessments, emotional distress was lower post-intervention but not 3\u00a0months later, and leader burnout was not significantly different at either assessment.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Peer support group leader education improved leader self-efficacy substantially. The program could be easily adapted for support group leaders in other rare diseases.<\/jats:p>\n                <jats:p><jats:italic>Trial registration:<\/jats:italic><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03965780\">NCT03965780<\/jats:ext-link>; registered on May 29, 2019.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-022-02552-x","type":"journal-article","created":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T21:02:41Z","timestamp":1666990961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effects of a support group leader education program jointly developed by health professionals and patients on peer leader self-efficacy among leaders of scleroderma support groups: a two-arm parallel partially nested randomised controlled trial"],"prefix":"10.1186","volume":"17","clinical-trial-number":[{"clinical-trial-number":"nct03965780","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5644-8432","authenticated-orcid":false,"given":"Brett D.","family":"Thombs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Levis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Eve","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Dyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Nordlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylene","family":"Aguila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Bourgeault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violet","family":"Konrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Sauv\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerri","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"\u00d8stb\u00f8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander W.","family":"Levis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Kwakkenbos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa L.","family":"Malcarne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghassan","family":"El-Baalbaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Wurz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Nicole","family":"Culos-Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Platt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"SPIN-SSLED Support Group Leader Advisory Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Elrod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Fortun\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Gietzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Gottesman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Rozee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,28]]},"reference":[{"key":"2552_CR1","unstructured":"Kole A, Faurisson F. The Voice of 12,000 Patients. Experiences and Expectations of Rare Disease Patients on Diagnosis and Care in Europe: EURORDIS-Rare Diseases Eu; 2009. http:\/\/www.eurordis.org\/IMG\/pdf\/voice_12000_patients\/EURORDISCARE_FULLBOOKr.pdf. Accessed September 28, 2022."},{"key":"2552_CR2","unstructured":"European Organisation for Rare Diseases. Rare diseases: understanding this public health priority; 2005. https:\/\/www.eurordis.org\/IMG\/pdf\/princeps_document-EN.pdf. Accessed September 28, 2022."},{"issue":"4","key":"2552_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1369-7625.2009.00552.x","volume":"12","author":"C Huyard","year":"2009","unstructured":"Huyard C. What, if anything, is specific about having a rare disorder? Patients\u2019 judgements on being ill and being rare. Health Expect. 2009;12(4):361\u201370.","journal-title":"Health Expect"},{"issue":"1","key":"2552_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1172-8-22","volume":"8","author":"M Anderson","year":"2013","unstructured":"Anderson M, Elliott EJ, Zurynski YA. Australian families living with rare disease: Experiences of diagnosis, health services use and needs for psychosocial support. Orphanet J Rare Dis. 2013;8(1):1.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"2552_CR5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1177\/1527154411404243","volume":"12","author":"WP Holtzclaw","year":"2011","unstructured":"Holtzclaw WP. Policy framework for rare disease health disparities. Policy Polit Nurs Pract. 2011;12(2):114\u20138.","journal-title":"Policy Polit Nurs Pract"},{"issue":"9444","key":"2552_CR6","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/S0140-6736(04)17277-2","volume":"364","author":"S Newman","year":"2004","unstructured":"Newman S, Steed L, Mulligan K. Self-management interventions for chronic illness. Lancet. 2004;364(9444):1523\u201337.","journal-title":"Lancet"},{"issue":"2","key":"2552_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1037\/0003-066X.55.2.205","volume":"55","author":"KP Davison","year":"2000","unstructured":"Davison KP, Pennebaker JW, Dickerson SS. Who talks? The social psychology of illness support groups. Am Psychol. 2000;55(2):205\u201317.","journal-title":"Am Psychol"},{"issue":"8","key":"2552_CR8","doi-asserted-by":"publisher","first-page":"e003563","DOI":"10.1136\/bmjopen-2013-003563","volume":"3","author":"L Kwakkenbos","year":"2013","unstructured":"Kwakkenbos L, Jewett LR, Baron M, Bartlett SJ, Furst D, Gottesman K, et al. The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease context. BMJ Open. 2013;3(8):e003563.","journal-title":"BMJ Open"},{"issue":"12","key":"2552_CR9","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1007\/s00103-007-0382-8","volume":"50","author":"A Reimann","year":"2007","unstructured":"Reimann A, Bend J, Dembski B. Patient-centred care in rare diseases: a patient organisations\u2019 perspective. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007;50(12):1484\u201393.","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"8","key":"2552_CR10","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1080\/09638288.2017.1416497","volume":"41","author":"ST Gumuchian","year":"2019","unstructured":"Gumuchian ST, Delisle VC, Kwakkenbos L, Pepin M, Carrier ME, Malcarne VL, et al. Reasons for attending support groups and organizational preferences: the European scleroderma support group members survey. Disabil Rehabil. 2019;41(8):974\u201382.","journal-title":"Disabil Rehabil"},{"issue":"3","key":"2552_CR11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1177\/2397198319849806","volume":"4","author":"M P\u00e9pin","year":"2019","unstructured":"P\u00e9pin M, Kwakkenbos L, Carrier ME, Pel\u00e1ez S, El-Baalbaki G, Malcarne V, et al. Reasons for attending support groups and organizational preferences: a replication study using the North American Scleroderma Support Group Survey. J Scleroderma Relat Disord. 2019;4(3):173\u201386.","journal-title":"J Scleroderma Relat Disord"},{"key":"2552_CR12","doi-asserted-by":"crossref","unstructured":"Delisle VC, Gumuchian ST, El-Baalbaki G, Korner A, Malcarne VL, Pelaez S, et al. Training and support needs of scleroderma support group facilitators: the North American Scleroderma Support Group Facilitators Survey. Disabil Rehabil. 2018:1\u20136.","DOI":"10.1037\/t81623-000"},{"issue":"9629","key":"2552_CR13","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1016\/S0140-6736(08)60875-2","volume":"371","author":"S Ayme","year":"2008","unstructured":"Ayme S, Kole A, Groft S. Empowerment of patients: lessons from the rare diseases community. Lancet. 2008;371(9629):2048\u201351.","journal-title":"Lancet"},{"key":"2552_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1023\/A:1023509117524","volume":"12","author":"VS Helgeson","year":"2003","unstructured":"Helgeson VS. Social support and quality of life. Qual Life Res. 2003;12:25\u201331.","journal-title":"Qual Life Res"},{"issue":"10","key":"2552_CR15","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1037\/hea0000905","volume":"39","author":"BA Bryson","year":"2020","unstructured":"Bryson BA, Bogart KR. Social support, stress, and life satisfaction among adults with rare diseases. Health Psychol. 2020;39(10):912\u201320.","journal-title":"Health Psychol"},{"key":"2552_CR16","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1177\/1094670515583271","volume":"18","author":"T Yao","year":"2015","unstructured":"Yao T, Zheng Q, Fan X. The impact of online social support on patients\u2019 quality of life and the moderating role of social exclusion. J Serv Res. 2015;18:369\u201383.","journal-title":"J Serv Res"},{"key":"2552_CR17","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s10900-007-9066-4","volume":"33","author":"TW Strine","year":"2008","unstructured":"Strine TW, Chapman DP, Balluz LS, Moriarty DG, Mokdad AH. The associations between life satisfaction and health-related quality of life, chronic illness, and health behaviors among U.S. community-dwelling adults. J Commun Health. 2008;33:40\u201350.","journal-title":"J Commun Health"},{"key":"2552_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/s13023-017-0730-1","volume":"12","author":"KR Bogart","year":"2017","unstructured":"Bogart KR, Irvin VL. Health-related quality of life among adults with diverse rare disorders. Orphanet J Rare Dis. 2017;12:177.","journal-title":"Orphanet J Rare Dis"},{"key":"2552_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1037\/sah0000018","volume":"1","author":"KR Bogart","year":"2016","unstructured":"Bogart KR, Hemmesch AR. Benefits of support conferences for parents of and people with moebius syndrome. Stigma Health. 2016;1:109\u201321.","journal-title":"Stigma Health"},{"key":"2552_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s13023-020-01660-w","volume":"16","author":"MK Depping","year":"2021","unstructured":"Depping MK, Uhlenbusch N, von Kodolitsch Y, Klose HFE, Mautner VF, L\u00f6we B. Supportive care needs of patients with rare chronic diseases: multi-method, cross-sectional study. Orphanet J Rare Dis. 2021;16:44.","journal-title":"Orphanet J Rare Dis"},{"key":"2552_CR21","unstructured":"Limb L, Nutt S, Sen A. Experiences of rare diseases: An insight from patients and families. Rare Disease UK. https:\/\/www.raredisease.org.uk\/media\/1594\/rduk-family-report.pdf. Accessed September 28, 2022."},{"issue":"5","key":"2552_CR22","first-page":"56","volume":"100","author":"VC Delisle","year":"2016","unstructured":"Delisle VC, Gumuchian ST, Pelaez S, Malcarne VL, El-Baalbaki G, Korner A, et al. Reasons for non-participation in scleroderma support groups. Clin Exp Rheumatol. 2016;100(5):56\u201362.","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"2552_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/acr.23220","volume":"70","author":"ST Gumuchian","year":"2018","unstructured":"Gumuchian ST, Delisle VC, Pel\u00e1ez S, Malcarne VL, El-Baalbaki G, Kwakkenbos L, et al. Reasons for not participating in scleroderma patient support groups: a cross-sectional study. Arthritis Care Res. 2018;70(2):275\u201383.","journal-title":"Arthritis Care Res"},{"issue":"9","key":"2552_CR24","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1080\/09638288.2019.1656292","volume":"43","author":"L Kwakkenbos","year":"2021","unstructured":"Kwakkenbos L, Carboni-Jim\u00e9nez A, Carrier ME, P\u00e9pin M, Pel\u00e1ez S, Malcarne VL, et al. Reasons for not participating in scleroderma patient support groups: a comparison of results from the North American and European scleroderma support group surveys. Disabil Rehabil. 2021;43(9):1279\u201386.","journal-title":"Disabil Rehabil"},{"key":"2552_CR25","unstructured":"National Voices. Peer support: what is it and does it work? 2015. www.nationalvoices.org.uk\/publications\/our-publications\/peer-support. Accessed September 28, 2022."},{"issue":"12","key":"2552_CR26","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1002\/cncr.22719","volume":"109","author":"JE Owen","year":"2007","unstructured":"Owen JE, Goldstein MS, Lee JH, Breen N, Rowland JH. Use of health-related and cancer-specific support groups among adult cancer survivors. Cancer. 2007;109(12):2580\u20139.","journal-title":"Cancer"},{"issue":"3","key":"2552_CR27","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.healthpol.2014.10.017","volume":"119","author":"LP Fumagalli","year":"2015","unstructured":"Fumagalli LP, Radaelli G, Lettieri E, Bertele P, Masella C. Patient empowerment and its neighbors: clarifying the boundaries and their mutual relationships. Health Policy. 2015;119(3):384\u201394.","journal-title":"Health Policy"},{"issue":"12","key":"2552_CR28","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.pec.2016.07.026","volume":"99","author":"EM Castro","year":"2016","unstructured":"Castro EM, van Regenmortal T, Vanhaecht K, Sermeus W, van Hecke A. Patient empowerment, patient participation and patient-centeredness in hospital care: A concept analysis based on a literature review. Patient Educ Couns. 2016;99(12):1923\u201339.","journal-title":"Patient Educ Couns"},{"issue":"9","key":"2552_CR29","doi-asserted-by":"publisher","first-page":"e329","DOI":"10.2196\/jmir.7809","volume":"19","author":"T Risling","year":"2017","unstructured":"Risling T, Martinez J, Young J, Thorp-Froslie N. Evaluating patient empowerment in association with eHealth technology: scoping review. J Med Internet Res. 2017;19(9):e329.","journal-title":"J Med Internet Res"},{"issue":"2","key":"2552_CR30","doi-asserted-by":"publisher","first-page":"e14321","DOI":"10.2196\/14321","volume":"8","author":"SN Hossain","year":"2021","unstructured":"Hossain SN, Jaglal SB, Shepherd J, et al. Web-based peer support interventions for adults living with chronic conditions: scoping review. JMIR Rehab Assist Technol. 2021;8(2):e14321.","journal-title":"JMIR Rehab Assist Technol"},{"issue":"4","key":"2552_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11926-019-0808-y","volume":"21","author":"DB Rice","year":"2019","unstructured":"Rice DB, Thombs BD. Support groups in scleroderma. Curr Rheumatol Rep. 2019;21(4):9.","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"2552_CR32","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40271-016-0213-9","volume":"10","author":"VC Delisle","year":"2017","unstructured":"Delisle VC, Gumuchian ST, Rice DB, Levis AW, Kloda LA, K\u00f6rner A, et al. Perceived benefits and factors that influence the ability to establish and maintain patient support groups in rare diseases: a scoping review. Patient. 2017;10(3):283\u201393.","journal-title":"Patient"},{"issue":"6","key":"2552_CR33","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/her\/16.6.693","volume":"16","author":"M White","year":"2001","unstructured":"White M, Dorman SM. Receiving social support online: implications for health education. Health Educ Res. 2001;16(6):693\u2013707.","journal-title":"Health Educ Res"},{"issue":"8","key":"2552_CR34","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1046\/j.1525-1497.1997.00084.x","volume":"12","author":"JD Culver","year":"1997","unstructured":"Culver JD, Gerr F, Frumkin H. Medical information on the Internet: a study of an electronic bulletin board. J Gen Intern Med. 1997;12(8):466\u201370.","journal-title":"J Gen Intern Med"},{"issue":"3","key":"2552_CR35","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/016128400248068","volume":"21","author":"DL Finfgeld","year":"2000","unstructured":"Finfgeld DL. Therapeutic groups online: the good, the bad, and the unknown. Issues Ment Health Nurs. 2000;21(3):241\u201355.","journal-title":"Issues Ment Health Nurs"},{"key":"2552_CR36","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.jad.2020.11.094","volume":"281","author":"Y Tong Tan","year":"2021","unstructured":"Tong Tan Y, Rehm IC, Stevenson JL, De Foe A. Social media peer support groups for obsessive-compulsive and related disorders: understanding the predictors of negative experiences. J Affect Disord. 2021;281:661\u201372.","journal-title":"J Affect Disord"},{"issue":"1","key":"2552_CR37","doi-asserted-by":"publisher","first-page":"e022642","DOI":"10.1136\/bmjopen-2018-022642","volume":"9","author":"A Palant","year":"2019","unstructured":"Palant A, Himmel W. Are there also negative effects of social support? A qualitative study of patients with inflammatory bowel disease. BMJ Open. 2019;9(1):e022642.","journal-title":"BMJ Open"},{"issue":"2","key":"2552_CR38","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.chb.2007.01.014","volume":"24","author":"CF van Uden-Kraan","year":"2008","unstructured":"van Uden-Kraan CF, Drossaert CHC, Taal E, Lebrun CEI, Drossaers-Bakker KW, Smit WM, et al. Coping with somatic illnesses in online support groups: do the feared disadvantages actually occur? Comput Hum Behav. 2008;24(2):309\u201324.","journal-title":"Comput Hum Behav"},{"issue":"1","key":"2552_CR39","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1464-410X.2006.06545.x","volume":"99","author":"SK Steginga","year":"2007","unstructured":"Steginga SK, Smith DP, Pinnock C, Metcalfe R, Gardiner RA, Dunn J. Clinicians\u2019 attitudes to prostate cancer peer-support groups. BJU Int. 2007;99(1):68\u201371.","journal-title":"BJU Int"},{"key":"2552_CR40","doi-asserted-by":"publisher","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","volume":"1","author":"Y Allanore","year":"2015","unstructured":"Allanore Y, Simms R, Distler O, Trojanowska M, Pope J, Denton CP, et al. Systemic sclerosis. Nat Rev Dis Primers. 2015;1:15002.","journal-title":"Nat Rev Dis Primers"},{"key":"2552_CR41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13643-019-0981-0","volume":"8","author":"KA Turner","year":"2019","unstructured":"Turner KA, Rice DB, Carboni-Jim\u00e9nez A, Boruff J, Thombs BD. Effects of training and support programs for leaders of illness-based support groups: commentary and updated evidence. Syst Rev. 2019;8:67.","journal-title":"Syst Rev"},{"issue":"3","key":"2552_CR42","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/jcop.21677","volume":"43","author":"R Zordan","year":"2015","unstructured":"Zordan R, Butow P, Kirsten L, Charles M, Hobbs K, Batterby E, et al. Supporting the supporters: a randomized controlled trial of interventions to assist the leaders of cancer support groups. J Commu Psychol. 2015;43(3):261\u201377.","journal-title":"J Commu Psychol"},{"key":"2552_CR43","doi-asserted-by":"publisher","first-page":"e029935","DOI":"10.1136\/bmjopen-2019-029935","volume":"9","author":"BD Thombs","year":"2019","unstructured":"Thombs BD, Dyas L, P\u00e9pin M, Aguila K, Carrier ME, Tao L, et al. Scleroderma Patient-centered Intervention Network Support group Leader EDucation (SPIN-SSLED) Program: non-randomised feasibility trial. BMJ Open. 2019;9:e029935.","journal-title":"BMJ Open"},{"key":"2552_CR44","volume-title":"Self-efficacy: the exercise of control","author":"A Bandura","year":"1997","unstructured":"Bandura A. Self-efficacy: the exercise of control. New York: W.H. Freeman and Company; 1997."},{"key":"2552_CR45","doi-asserted-by":"publisher","first-page":"E103","DOI":"10.5888\/pcd11.130328","volume":"11","author":"S Ruiz","year":"2014","unstructured":"Ruiz S, Brady TJ, Glasgow RE, Birkel R, Spafford M. Chronic condition self-management surveillance: what is and what should be measured? Prev Chronic Dis. 2014;11:E103.","journal-title":"Prev Chronic Dis"},{"issue":"2","key":"2552_CR46","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.pec.2012.11.015","volume":"91","author":"P Gulbrandsen","year":"2013","unstructured":"Gulbrandsen P, Jensen BF, Finset A, Blanch-Hartigan D. Long-term effect of communication training on the relationship between physicians\u2019 self-efficacy and performance. Patient Educ Couns. 2013;91(2):180\u20135.","journal-title":"Patient Educ Couns"},{"issue":"4","key":"2552_CR47","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3102\/0034654315626801","volume":"86","author":"M Zee","year":"2016","unstructured":"Zee M, Koomen HMY. Teacher self-efficacy and its effects on classroom processes, student academic achievement, and teacher well-being: a synthesis of 40 years of research. Rev Educ Res. 2016;86(4):981\u20131015.","journal-title":"Rev Educ Res"},{"issue":"1","key":"2552_CR48","doi-asserted-by":"publisher","first-page":"106","DOI":"10.5301\/jsrd.5000260","volume":"3","author":"NE Pal","year":"2018","unstructured":"Pal NE, Gumuchian ST, Delisle VC, P\u00e9pin M, Malcarne VL, Carrier ME, et al. Development and preliminary validation of the Scleroderma Support Group Leader Self-efficacy Scale. J Scleroderma Relat Disord. 2018;3(1):106\u201311.","journal-title":"J Scleroderma Relat Disord"},{"issue":"1\u20133","key":"2552_CR49","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jad.2008.06.026","volume":"114","author":"K Kroenke","year":"2009","unstructured":"Kroenke K, Strine TW, Spitzer RL, Williams JBW, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord. 2009;114(1\u20133):163\u201373.","journal-title":"J Affect Disord"},{"issue":"3","key":"2552_CR50","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1080\/02678370500340728","volume":"19","author":"JRB Halbesleben","year":"2005","unstructured":"Halbesleben JRB, Demerouti E. The construct validity of an alternative measure of burnout: Investigating the English translation of the Oldenburg Burnout Inventory. Work Stress. 2005;19(3):208\u201320.","journal-title":"Work Stress"},{"issue":"1","key":"2552_CR51","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1300\/J079v28n01_03","volume":"28","author":"R Galindo-Kuhn","year":"2002","unstructured":"Galindo-Kuhn R, Guzley RM. The volunteer satisfaction index. J Soc Serv Res. 2002;28(1):45\u201368.","journal-title":"J Soc Serv Res"},{"issue":"1","key":"2552_CR52","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/dar.12522","volume":"37","author":"PJ Kelly","year":"2018","unstructured":"Kelly PJ, Kyngdon F, Ingram I, Deane FP, Baker AL, Osborne BA. The client satisfaction questionnaire-8: psychometric properties in a cross-sectional survey of people attending residential substance abuse treatment. Drug Alcohol Rev. 2018;37(1):79\u201386.","journal-title":"Drug Alcohol Rev"},{"key":"2552_CR53","unstructured":"Lohr S, Schochet PZ, Sanders E. Partially nested randomized controlled trials in education research: a guide to design and analysis. In: NCER 2014\u20132000. National Center for Education Research. 2014."},{"key":"2552_CR54","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.a2390","volume":"337","author":"M Zwarenstein","year":"2008","unstructured":"Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, Haynes B, et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ. 2008;337: a2390.","journal-title":"BMJ"},{"key":"2552_CR55","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h2147","volume":"350","author":"K Loudon","year":"2015","unstructured":"Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M. The PRECIS-2 tool: designing trials that are fit for purpose. BMJ. 2015;350: h2147.","journal-title":"BMJ"},{"issue":"7127","key":"2552_CR56","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1136\/bmj.316.7127.285","volume":"316","author":"M Roland","year":"1998","unstructured":"Roland M, Torgerson DJ. Understanding controlled trials: what are pragmatic trials? BMJ. 1998;316(7127):285.","journal-title":"BMJ"},{"key":"2552_CR57","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12916-018-1038-2","volume":"16","author":"R Dal-R\u00e9","year":"2018","unstructured":"Dal-R\u00e9 R, Janiaud P, Ioannidis JPA. Real-world evidence: how pragmatic are randomized controlled trials labeled as pragmatic? BMC Med. 2018;16:49.","journal-title":"BMC Med"},{"key":"2552_CR58","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1186\/s13063-019-3747-z","volume":"20","author":"BD Thombs","year":"2019","unstructured":"Thombs BD, Aguila K, Dyas L, Carrier ME, Fedoruk C, Horwood L, et al. Protocol for a partially nested randomized controlled trial to evaluate the effectiveness of the Scleroderma Patient-centered Intervention Network Support Group Leader EDucation (SPIN-SSLED) Program. Trials. 2019;20:717.","journal-title":"Trials"},{"key":"2552_CR59","doi-asserted-by":"publisher","first-page":"c869","DOI":"10.1136\/bmj.c869","volume":"340","author":"D Moher","year":"2010","unstructured":"Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.","journal-title":"BMJ"},{"issue":"4","key":"2552_CR60","doi-asserted-by":"publisher","first-page":"295","DOI":"10.7326\/0003-4819-148-4-200802190-00008","volume":"148","author":"I Boutron","year":"2008","unstructured":"Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, CONSORT Group. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008;148(4):295\u2013309.","journal-title":"Ann Intern Med"},{"key":"2552_CR61","doi-asserted-by":"publisher","first-page":"e5661","DOI":"10.1136\/bmj.e5661","volume":"345","author":"MK Campbell","year":"2012","unstructured":"Campbell MK, Piaggio G, Elbourne DR, Altman DG, CONSORT Group. CONSORT 2010 statement: extension to cluster randomised trials. BMJ. 2012;345:e5661.","journal-title":"BMJ"},{"issue":"4","key":"2552_CR62","doi-asserted-by":"publisher","first-page":"e126","DOI":"10.2196\/jmir.1923","volume":"13","author":"G Eysenbach","year":"2011","unstructured":"Eysenbach G, CONSORT-EHEALTH Group. CONSORT-EHEALTH: improving and standardizing evaluation reports of Web-based and mobile health interventions. J Med Internet Res. 2011;13(4):e126.","journal-title":"J Med Internet Res"},{"key":"2552_CR63","unstructured":"The Scleroderma Support Group Leader Education (SPIN-SSLED) Program. https:\/\/www.spinsclero.com\/en\/projects\/ssled. Accessed September 28, 2022."},{"issue":"9305","key":"2552_CR64","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S0140-6736(02)07683-3","volume":"359","author":"KF Schulz","year":"2002","unstructured":"Schulz KF, Grimes DA. Generation of allocation sequences in randomised trials: chance, not choice. Lancet. 2002;359(9305):515\u20139.","journal-title":"Lancet"},{"key":"2552_CR65","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1023\/B:EDPR.0000034022.16470.f3","volume":"16","author":"CE Hmelo-Silver","year":"2004","unstructured":"Hmelo-Silver CE. Problem-based learning: what and how do students learn? Educ Psychol Rev. 2004;16:235\u201366.","journal-title":"Educ Psychol Rev"},{"key":"2552_CR66","unstructured":"Torp L, Sage S. Problems as possibilities: problem-based learning for K-16 education. 2nd ed. Alexandria, Va.: Association for Supervision and Curriculum Development; 2002."},{"issue":"1","key":"2552_CR67","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s10488-010-0321-0","volume":"38","author":"SK Schoenwald","year":"2011","unstructured":"Schoenwald SK, Garland AF, Chapman JE, Frazier SL, Sheidow AJ, Southam-Gerow MA. Toward the effective and efficient measurement of implementation fidelity. Adm Policy Ment Health. 2011;38(1):32\u201343.","journal-title":"Adm Policy Ment Health"},{"issue":"5","key":"2552_CR68","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1037\/0278-6133.23.5.443","volume":"23","author":"AJ Bellg","year":"2004","unstructured":"Bellg AJ, Borrelli B, Resnick B, Hecht J, Minicucci DS, Ory M, et al. Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium. Health Psychol. 2004;23(5):443\u201351.","journal-title":"Health Psychol"},{"issue":"2","key":"2552_CR69","doi-asserted-by":"publisher","first-page":"R47","DOI":"10.1186\/ar3760","volume":"14","author":"MA Oude Voshaar","year":"2012","unstructured":"Oude Voshaar MA, Ten Klooster PM, Taal E, Krishnan E, van de Laar MA. Dutch translation and cross-cultural adaptation of the PROMIS\u00ae physical function item bank and cognitive pre-test in Dutch arthritis patients. Arth Res Ther. 2012;14(2):R47.","journal-title":"Arth Res Ther"},{"key":"2552_CR70","first-page":"CD011175","volume":"10","author":"MR Asnani","year":"2016","unstructured":"Asnani MR, Quimby KR, Bennett NR, Francis DK. Interventions for patients and caregivers to improve knowledge of sickle cell disease and recognition of its related complications. Cochrane Database Syst Rev. 2016;10:CD011175.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2552_CR71","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10802-007-9201-9","volume":"36","author":"JW Kaminski","year":"2008","unstructured":"Kaminski JW, Valle LA, Filene JH, Boyle CL. A meta-analytic review of components associated with parent training program effectiveness. J Abnorm Child Psychol. 2008;36(4):567\u201389.","journal-title":"J Abnorm Child Psychol"},{"issue":"10","key":"2552_CR72","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1111\/j.1464-5491.2005.01618.x","volume":"22","author":"TA Armour","year":"2005","unstructured":"Armour TA, Norris SL, Jack L Jr, Zhang X, Fisher L. The effectiveness of family interventions in people with diabetes mellitus: a systematic review. Diabet Med. 2005;22(10):1295\u2013305.","journal-title":"Diabet Med"},{"key":"2552_CR73","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2147\/PRBM.S192571","volume":"12","author":"X Jiang","year":"2019","unstructured":"Jiang X, Wang J, Lu Y, Jiang H, Li M. Self-efficacy-focused education in persons with diabetes: a systematic review and meta-analysis. Psychol Res Behav Manag. 2019;12:67\u201379.","journal-title":"Psychol Res Behav Manag"},{"issue":"4","key":"2552_CR74","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/jan.13163","volume":"73","author":"FF Zhao","year":"2017","unstructured":"Zhao FF, Suhonen R, Koskinen S, Leino-Kilpi H. Theory-based self-management educational interventions on patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. J Adv Nurs. 2017;73(4):812\u201333.","journal-title":"J Adv Nurs"},{"issue":"2","key":"2552_CR75","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1365-3016.2007.00901.x","volume":"22","author":"M Taljaard","year":"2008","unstructured":"Taljaard M, Donner A, Villar J, Wojdyla D, Velazco A, Bataglia V, et al. Intracluster correlation coefficients from the 2005 WHO Global Survey on Maternal and Perinatal Health: implications for implementation research. Paediatr Perinat Epidemiol. 2008;22(2):117\u201325.","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"4","key":"2552_CR76","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0197-2456(02)00208-8","volume":"23","author":"L Smeeth","year":"2002","unstructured":"Smeeth L, Ng ES. Intraclass correlation coefficients for cluster randomized trials in primary care: data from the MRC Trial of the Assessment and Management of Older People in the Community. Control Clin Trials. 2002;23(4):409\u201321.","journal-title":"Control Clin Trials"},{"issue":"1","key":"2552_CR77","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/00001648-199401000-00013","volume":"5","author":"PJ Hannan","year":"1994","unstructured":"Hannan PJ, Murray DM, Jacobs DR Jr, McGovern PG. Parameters to aid in the design and analysis of community trials: intraclass correlations from the Minnesota Heart Health Program. Epidemiology. 1994;5(1):88\u201395.","journal-title":"Epidemiology"},{"key":"2552_CR78","unstructured":"National Institute for Clinical Excellence. Depression: management of depression in primary and secondary care: National Institute for Clinical Excellence; 2004."},{"issue":"1","key":"2552_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates D, Machler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67(1):1\u201348.","journal-title":"J Stat Softw"},{"key":"2552_CR80","doi-asserted-by":"publisher","DOI":"10.1002\/9780470316696","volume-title":"Multiple imputation for nonresponse in surveys","author":"DB Rubin","year":"1987","unstructured":"Rubin DB. Multiple imputation for nonresponse in surveys. New York: Wiley; 1987."},{"key":"2552_CR81","volume-title":"statistical power analysis for the behavioural sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. statistical power analysis for the behavioural sciences. New York: Academic Press; 1988."}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02552-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02552-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02552-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T10:06:40Z","timestamp":1667124400000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02552-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,28]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2552"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02552-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,28]]},"assertion":[{"value":"5 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was obtained from the Research Ethics Committee of the Centre int\u00e9gr\u00e9 universitaire de sant\u00e9 et de services sociaux du Centre-Ouest-de-l'\u00cele-de-Montr\u00e9al (#2020-1780). All participants provided informed consent via a web-based electronic consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have completed the ICJME uniform disclosure form and declare: no support from any organisation for the submitted work; no financial relationships <i>w<\/i>ith any organisations that might have an interest in the submitted work in the previous 3 years. All authors declare no other relationships or activities that could appear to have influenced the submitted work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"396"}}